Imperial College London Featured PhD Programmes
University of Warwick Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Reading Featured PhD Programmes
"natural"×
10 miles

Cancer / Oncology (natural) PhD Projects, Programs & Scholarships

We have 24 Cancer / Oncology (natural) PhD Projects, Programs & Scholarships

  • "natural" ×
  • Cancer / Oncology×
  • clear all
Order by 
Showing 1 to 24 of 24
  Evaluation of natural and novel tumour-selective cannabinoids in melanoma progression and metastases
  Dr A Idris, Dr S Danson
Application Deadline: 1 July 2020

Funding Type

PhD Type

The majority of deaths from melanoma following conventional therapies are a result of metastases.
  Development of new drugs to reverse tumour resistance to chemotherapy
  Research Group: Biomedical Research Group
  Dr C Erridge, Dr G Pirianov
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Investigating the anti-cancer effect of hop β -acid Lupulone and its synthetic derivatives on breast cancer cells
  Research Group: Biomedical Research Group
  Dr G Pirianov
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Fully-funded PhD positions in several natural sciences & engineering disciplines

Funding Type

PhD Type

Join an internationally renowned scientific community with the Hector FellowPhD program. PhD students benefit not only from the experience of the program, but also from the network of Hector Fellows.
  Unravelling the mysteries of retinoid signalling
  Dr E Pohl, Prof J Endicott
Application Deadline: 6 March 2020

Funding Type

PhD Type

Retinoids, such as all-trans-retinoic acid (ATRA), are a class of endogenous molecules derived from Vitamin A. These compounds control a wide range of cellular processes in chordates, including differentiation, proliferation and apoptosis, by binding one or more of related transcriptional receptors in the cell nucleus.
  Doctor of Engineering (EngD): Answering Questions about Medical Images (Canon Medical Research Europe, Ltd)
  Research Group: CDT in Applied Photonics
  Prof D Reid, Dr F Deligianni, Dr J Dalton
Application Deadline: 28 February 2020

Funding Type

PhD Type

Visual Question Answering (VQA) [1] is the task of answering free-text questions about the content of images. For example, given an image of a room - ‘What colour is the chair standing in the corner?’ - answering this question requires joint understanding of vision, language, spatial reasoning, and common sense.
  Targeting the cancer – approaches to the design and synthesis of new anti-cancer agents (SEARCEYMU20SCIPVC)
  Prof M Searcey, Dr A Beekman
Application Deadline: 17 April 2020

Funding Type

PhD Type

The last few years have seen the introduction to the clinic of antibody-drug conjugates or ADCs that have revolutionised the treatment of some cancers.1 They enable the targeting of highly potent molecules to their site of action- the tumour cell – so that side effects should be diminished as off target effects are reduced.
  Cell-permeable cyclic peptide library generation for target-based screening
  Prof A Kawamura, Prof M Waring, Dr SL Cobb
Application Deadline: 6 March 2020

Funding Type

PhD Type

Peptides hold enormous promise as chemical tools for selective intervention in biology. They can target chemical space distinct from that of small molecules and their chemical diversity provides high specificity and affinity or target binding.
  Design and synthesis of DNA encoded libraries of unnatural peptides to discover specific chemical probes
  Prof M Waring, Prof A Kawamura, Prof M Noble, Dr SL Cobb
Application Deadline: 6 March 2020

Funding Type

PhD Type

Peptides of allow the rapid identification of protein ligands from huge libraries of genetically encoded peptides, including cyclic peptides.
  Molecular cancer therapeutics activated by radioisotope-generated Cerenkov radiation
  Dr J Knight, Dr R Pal, Dr K Rankin
Application Deadline: 6 March 2020

Funding Type

PhD Type

The beta-particles emitted by certain medical radioisotopes can travel faster than light through the human body. When this happens, a photonic boom - comparable to a sonic boom – releases energy in the form of Cerenkov radiation which has a characteristic blue glow.
  Transglutaminase 2 (TG2) as a novel cancer biomarker and target for chemotherapy
  Research Group: Biomedical Research Group
  Dr P Coussons, Dr C Pike
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  PhD Cancer Genetics - Examining how telomere dysfunction drives the evolution of the cancer genome
  Prof D Baird, Dr K Cleal
Application Deadline: 1 March 2020

Funding Type

PhD Type

Telomeres are structures that cap the ends of eukaryotic chromosomes, preventing the recognition and repair of the natural chromosomal terminus by the DNA damage response (DDR) apparatus.
  Developing New Tools for the Chemical Diversification of Peptide Scaffolds
  Dr SL Cobb, Prof A Kawamura, Prof M Waring
Application Deadline: 6 March 2020

Funding Type

PhD Type

Peptides are useful leads for the development of new drugs against a wide range of diseases. They occupy the chemical space between small molecules and antibodies and as such they can reach or selectively inhibit drug targets that these other molecules cannot.
  FGFR signalling in breast cancer
  Dr A Chioni
Applications accepted all year round

Funding Type

PhD Type

Growth factors are used during development to convey messages that tell cells to divide, survive, migrate and adopt a particular fate.
  PhD program in Molecular Inflammation, Molecular Medicine and Advanced Medical Biomarker Research

Funding Type

PhD Type

Projects starting October 1, 2020. Application deadline. March 30, 2020.
  Reversing multidrug chemoresistance in head and neck cancer
  Dr M T Teh
Applications accepted all year round

Funding Type

PhD Type

Background. Multidrug resistance renders chemotherapeutic treatment failure in large proportion of head and neck squamous cell carcinoma (HNSCC) patients requiring multimodal therapy involving chemotherapy in conjunction with surgery and/or radiotherapy.
  Defining the immune cells which best fight cancer
  Prof D Davis
Application Deadline: 4 March 2020

Funding Type

PhD Type

Arguably, immune therapies for cancer are at a tipping point. The success of therapies for some patients with some types of cancer has made it clear that immunotherapies can work.
  Investigating the role of DNA structures genetic diseases such as cancer and diabetes (WALLERZU20SF)
  Dr Z Waller, Dr C Morris
Application Deadline: 31 May 2020

Funding Type

PhD Type

It is often assumed that DNA exists only as the iconic Watson-Crick double helix but it can actually adopt many different types of structure depending on the sequence and environmental conditions.
  Metabolic reprogramming in cancer: starving tumors of essential nutrients to promote cell death
  Dr S Papa
Applications accepted all year round

Funding Type

PhD Type

All the cells in our bodies are programmed to die. As they get older, our cells accumulate toxic molecules that make them sick. In response, they eventually break down and die, clearing the way for new, healthy cells to grow.
  Targeting cannabinoids to the gut-associated lymphoid tissue (GALT) for improved treatment of autoimmune diseases
  Dr P Gershkovich
Applications accepted all year round

Funding Type

PhD Type

Autoimmune diseases are conditions that are triggered by the immune system initiating an attack on the body’s own molecules. The causes of such attacks in most cases are unknown, but a number of studies suggest that they are associated with factors such as genetics, infections and environment.
  Exosomes in oncolytic virotherapy
  Prof L Seymour, Dr K Fisher
Application Deadline: 3 March 2020

Funding Type

PhD Type

THE PROJECT. Oncolytic viruses promise new opportunities for targeted cancer therapy, but spread of viruses through solid tumour masses is often limited.
  Neuropeptide Research - PhD Opportunity at a World Class Institution
  Assoc Prof M Muttenthaler, Assoc Prof I Vetter
Applications accepted all year round

Funding Type

PhD Type

We are seeking talented and highly motivated PhD candidates for the following multidisciplinary project. Neuropeptides are key mediators in many biological functions and understanding their interaction with target proteins is fundamental to unravel the underlying mechanism of diseases.
  PhD in Chemical Biology -- Neuropeptide Research -- University of Vienna
  Prof M Muttenthaler
Applications accepted all year round

Funding Type

PhD Type

Neuropeptides are key mediators in many biological functions and understanding their interaction with target proteins is fundamental to unravel the underlying mechanism of diseases.
  Harnessing Computational and Structural Biology Platforms for Drug Discovery
  Dr D Cole, Dr N Tatum, Dr E Pohl
Application Deadline: 6 March 2020

Funding Type

PhD Type

The spread of low-cost computing and development of data analysis techniques, such as machine learning, promise to improve our understanding of biological disease mechanisms and the design and prioritisation of new pharmaceutical molecules.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2020
All rights reserved.